QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene therapy manufacturing Expansion underscores the commitment of QIAGEN to help accelerate the development of safe and effective biotherapeutics New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow VENLO, the [...]

Hamilton, a global leader in life science technologies, is pleased to announce the launch of its new office, Hamilton Company Singapore Pte Ltd. This strategic expansion further strengthens Hamilton’s presence in the Pacific Rim and Asia, enabling direct sales and enhanced support for researchers in the region. The new office, located at the Singapore Science [...]

Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, today announced Sapio Release 25.4, introducing a new Biorepository Management solution, enhanced sample management capabilities, and platform-wide enhancements designed to streamline lab operations and support high-throughput research environments. New Biorepository Management Solution The new Sapio Biorepository solution gives [...]

Platform integrates yeast-based synthetic biology and robotics to streamline antibody discovery, eliminating lengthy steps and significantly reducing costs compared to traditional CRO outsourcing LONG ISLAND CITY, N.Y. – Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale [...]

ST. PAUL, Minn. -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G-Rex® Grant will be used to advance the manufacturing of their lead asset, MB-105, a novel investigational autologous CAR-T cell therapy targeting CD5 for patients with T-cell lymphomas. [...]

PROVIDENCE, R.I. -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, announces its achievement of ISO 9001:2015 certification. This internationally recognized standard demonstrates Nabsys' dedication to maintaining a robust and effective quality management system. The ISO 9001:2015 certification underscores Nabsys' ability to consistently deliver products and services that meet customer expectations and regulatory requirements. [...]

FREDERICK, MD. — RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, today announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science. This collaboration aims to accelerate the availability of new, potentially life-saving cell and exosome therapies that have the [...]

FORT MYERS, Fla. and FREMONT, Calif. -- NeoGenomics, Inc. (Nasdaq:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary ultra-high throughput next-generation sequencing (NGS) platform, today announced a collaboration to use Ultima's UG 100™ sequencing platform and its ppmSeq™ technology to advance NeoGenomics' ability to offer innovative clinical tests. [...]

MADISON, Wis. -- FUJIFILM Cellular Dynamics, Inc., a leading developer and manufacturer of human induced pluripotent stem cells (iPSC), today announces the appointment of Delara Motlagh, as its new chief operating officer (COO) effective immediately. In this role, Motlagh will drive the Company’s overall business and R&D strategy while leading operational execution for both domestic [...]

Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination BILLERICA, Mass. and MARLBOROUGH, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement. Under the amended terms, Quanterix will issue approximately 7.76 [...]